BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/11/2014 8:40:00 PM | Browse: 1097 | Download: 1516
 |
Received |
|
2013-07-30 10:39 |
 |
Peer-Review Started |
|
2013-07-30 21:21 |
 |
To Make the First Decision |
|
2013-08-08 11:18 |
 |
Return for Revision |
|
2013-08-20 20:09 |
 |
Revised |
|
2013-09-09 06:02 |
 |
Second Decision |
|
2013-10-21 17:27 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2013-10-22 07:00 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2013-10-29 08:26 |
 |
Typeset the Manuscript |
|
2013-11-23 12:35 |
 |
Publish the Manuscript Online |
|
2013-12-11 16:13 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Review |
Article Title |
Anti-angiogenic therapies for metastatic colorectal cancer: Current and future perspectives
|
Manuscript Source |
Invited Manuscript |
All Author List |
Inês Marques, António Araújo and Ramon Andrade de Mello |
Funding Agency and Grant Number |
|
Corresponding Author |
Ramon Andrade de Mello, MD, PhD, Department of Medical Oncology, Portuguese Oncology Institute, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal. ramondemello@gmail.com |
Key Words |
Colorectal cancer; Bevacizumab; Cetuximab; Aflibercept; FOLFOX; FOLFIRI |
Core Tip |
Metastatic colorectal cancer is a very aggressive disease. However, recently developed chemotherapeutic protocols and targeted drugs have emerged as a valuable tool for treating this set of patients. Our manuscript brings the readers current trends and future perspectives in this field. |
Publish Date |
2013-12-11 16:13 |
Citation |
Marques I, Araújo A, de Mello RA. Anti-angiogenic therapies for metastatic colorectal cancer: Current and future perspectives. World J Gastroenterol 2013; 19(44): 7955-7971 |
URL |
http://www.wjgnet.com/1007-9327/full/v19/i44/7955.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v19.i44.7955 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345